James Dale

James has over 18 years of experience in drug discovery, with expertise in synthetic and medicinal chemistry. At PharmEnable, he is leading the drug discovery and pipeline strategy, focusing on candidate progression to develop novel therapeutics. In his previous roles at Nanna Therapeutics, Benevolent AI and Novartis, James was responsible for leading teams to successfully generate pipelines of novel medicines. He completed his Ph.D. in synthetic organic chemistry at Cardiff University.